MCID and 2mg/kg x 2 dosage is now critical to ensuring both primary end points are met with a clear margin.
Should be interesting month or 2 ahead with potential trifecta of news.
The share price is unlikely to gravitate around PARO exercise if positive outcomes from agencies IMO.
- Forums
- ASX - By Stock
- PAR
- The (Painful) Competition
PAR
paradigm biopharmaceuticals limited..
Add to My Watchlist
1.22%
!
40.5¢

The (Painful) Competition, page-5
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
40.5¢ |
Change
-0.005(1.22%) |
Mkt cap ! $160.9M |
Open | High | Low | Value | Volume |
40.0¢ | 41.0¢ | 40.0¢ | $86.32K | 213.7K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 519 | 41.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
41.5¢ | 10600 | 4 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 519 | 0.410 |
2 | 12479 | 0.405 |
10 | 52448 | 0.400 |
8 | 130780 | 0.395 |
4 | 46650 | 0.390 |
Price($) | Vol. | No. |
---|---|---|
0.415 | 10600 | 4 |
0.420 | 58417 | 6 |
0.425 | 16532 | 6 |
0.430 | 34332 | 4 |
0.440 | 45000 | 2 |
Last trade - 11.19am 18/07/2025 (20 minute delay) ? |
Featured News
PAR (ASX) Chart |